Back to search
Acute Respiratory Insufficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Insufficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Insufficiency trials you may qualify forThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemi…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
Acute respiratory failure is a medical emergency rapidly leading to death, if not timely treated. Prompt Continuous Positive Airway Pressure (CPAP) improves pat…
Evaluation of awake prone position on ventilation inhomogeneity in COVID-19 associated respiratory failure.
The METEOR Trial will compare four implementation strategies-traditional online education, protocol-directed care, interprofessional education, and a combinatio…